comparemela.com

Latest Breaking News On - Jinky rosselli - Page 1 : comparemela.com

BioCryst Pharmaceuticals (BCRX) Q4 2023 Earnings Call Transcript

BCRX earnings call for the period ending December 31, 2023.

United statesDiscovery centerMaury raycroftCharlie gayerFrancois briseboisJessica fyeLiisa bayko evercoreBryan arnoldGena wang barclaysTazeen ahmadSerge belangerMaury raycroft jefferiesJon stonehouseAmerica merrill lynchFrancois brisebois oppenheimerSerge belanger needham

BioCryst Pharmaceuticals (BCRX) Q3 2023 Earnings Call Transcript

BCRX earnings call for the period ending September 30, 2023.

United kingdomUnited statesJon wollebenJinky rosselliGina wangAmerica merrill lynchAnthony doyleLiisa baykoJon stonehouseJacqueline lu oppenheimerLiisa bayko evercoreSerge belangerMaurice raycroftBrian abrahamsCharlie gayerSerge belanger needham

BioCryst Pharmaceuticals, Inc (NASDAQ:BCRX) Q3 2023 Earnings Call Transcript

Operator: Good morning and welcome to the BioCryst Pharmaceuticals Third Quarter 2023 Earnings Call. [Operator Instructions] Please note, this event is being recorded.

United statesStacy kuTazeen ahmadAnthony doyleCharlie gayerJohn bluthJon stonehouseJinky rosselliBiocryst pharmaceuticals incExchange commissionBiocryst pharmaceuticals third quarterEuropean bank stocks to investBiocryst pharmaceuticalsCall transcript novemberCryst pharmaceuticalsChief commercial officer

SPONSORED | BioCryst s First Rare Disease Drug Exceeds Expectations One Year into Launch

When presented with ORLADEYO, both patients and physicians recognized immediately the freedom gained with the once-daily prophylactic therapy and indicated a high willingness to use.

United statesUnited arab emiratesJinky rosselliCharlie gayerAmerican college of asthmaEuropean academy of allergyHuman plasmaEuropean academyClinical immunologyAmerican collegeUnited arabImportant safetyPonsored biocryst 39s first rare disease drug exceeds expectations one year into launch

vimarsana © 2020. All Rights Reserved.